Onxeo to study prostate cancer drug
French biotech company Onxeo S.A. has given an update on the clinical development program of…
January 27, 2023 - 4 minutes
Onxeo
Cancer drug for children and young people with glioblastoma given to patients in study
Clinical-stage bio company, Onxeo, has announced that the first patients have been enrolled and treated…
September 2, 2022 - 3 minutes
DNA Repair Treatment Shows Early Promise for Treating Cancer
Paris-based Onxeo has proved in humans the potential of a cancer treatment that interferes with…
November 5, 2018 - 3 minutes
Cancer Treatment Targeting DNA Repair is Tested in Humans for the First Time
Onxeo has initiated a Phase I trial testing its first-in-class cancer treatment that works by…
April 25, 2018 - 1 minute
French Nanoparticle Therapy Fails to Improve Liver Cancer Treatment in Phase III
Onxeo has announced Phase III results for its nanoparticle chemotherapy Livatag, which failed to improve…
September 12, 2017 - 2 minutes
It’s Blood Cancer Day, how is Biotech fixing it?
Today is the World Blood Cancer Day, an event to show solidarity to patients and…
May 28, 2016 - 4 minutes
French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients
Onxeo is the French orphan-drug specialist in Oncology who has various pipelines for certain cancers.…
November 11, 2015 - 3 minutes
Two French Biotechs are fighting in court…for nothing
We are all familiar with stories of lawsuits in the tech sector (e.g. remember the…
September 25, 2015 - 3 minutes
Onxeo confirms receipt of the $25M milestone payment from its US partner Spectrum
Onxeo, an innovative company specializing in the development of orphan oncology drugs, founded after the…
November 14, 2014 - 3 minutes
